📰 Arnaud Delepine News
Page 3 - Arnaud Delepine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arnaud Delepine. Real-time updates on events, politics, business and more.
January 7, 2022
Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia's AI-based capabilities and personalised medicine platform from target identification
January 7, 2022
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines * ... | January 7, 2022
December 16, 2021
16.12.2021 - Gilles SCHNEPP takes over as Chairman of the Appointments, Governance and CSR Committee of SanofiPARIS – December 16, 2021 - On December 15, 2021, the Board of Directors appointed Gilles Schnepp, an independent director of Sanofi, as Chairman ... Seite 1
December 15, 2021
Positive Phase 3 Dupixent® (dupilumab) data in children 6 months to 5 years with moderate-to-severe atopic dermatitis featured in RAD 2021 late-breaking session  Dupixent significantly improved skin clearance and reduced overall disease severity and itch in a Pivotal trial that met all primary and seco...
December 14, 2021
Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH's plenary and late-breaking
December 13, 2021
Positive Phase 3 Dupixent (dupilumab) data in children 6 months to 5 years with moderate-to-severe atopic dermatitis featured in RAD 2021 late-breaking session Dupixent significantly improved skin
December 9, 2021
New England Journal of Medicine publishes positive Phase 3 Dupixent® (dupilumab) results in children with moderate-to-severe asthma Dupixent significantly...
December 9, 2021
Investegate announcements from Sanofi - Aventis Groupe, New England Journal of Medicine publishes positive Phase 3 Dupixent® (dupilumab) results in children with moderate-to-severe asthma
December 8, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
December 8, 2021
New England Journal of Medicine publishes positive Phase 3 Dupixent (dupilumab) results in children with moderate-to-severe asthma Dupixent significantly reduced severe asthma attacks and improved